<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>28</volume><submitter>Penza V</submitter><pubmed_abstract>Mengovirus is an oncolytic picornavirus whose broad host range allows for testing in immunocompetent cancer models. Two pathogenicity-ablating approaches, polycytidine (polyC) tract truncation and microRNA (miRNA) targets insertion, eliminated the risk of encephalomyocarditis. To investigate whether a polyC truncated, miRNA-detargeted oncolytic Mengovirus might be boosted, we partially or fully rebuilt the polyC tract into the 5' noncoding region (NCR) of polyC-deleted (MC&lt;sub>0&lt;/sub>) oncolytic constructs (NC) carrying miRNA target (miRT) insertions to eliminate cardiac/muscular (miR-133b and miR-208a) and neuronal (miR-124) tropisms. PolyC-reconstituted viruses (MC&lt;sub>24&lt;/sub>-NC and MC&lt;sub>37&lt;/sub>-NC) replicated &lt;i>in vitro&lt;/i> and showed the expected tropism restrictions, but reduced</pubmed_abstract><journal>Molecular therapy oncolytics</journal><pagination>15-30</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9800256</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Polycytidine tract deletion from microRNA-detargeted oncolytic Mengovirus optimizes the therapeutic index in a murine multiple myeloma model.</pubmed_title><pmcid>PMC9800256</pmcid><pubmed_authors>Penza V</pubmed_authors><pubmed_authors>Schulze AJ</pubmed_authors><pubmed_authors>Nace RA</pubmed_authors><pubmed_authors>Russell SJ</pubmed_authors><pubmed_authors>Maroun JW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Polycytidine tract deletion from microRNA-detargeted oncolytic Mengovirus optimizes the therapeutic index in a murine multiple myeloma model.</name><description>Mengovirus is an oncolytic picornavirus whose broad host range allows for testing in immunocompetent cancer models. Two pathogenicity-ablating approaches, polycytidine (polyC) tract truncation and microRNA (miRNA) targets insertion, eliminated the risk of encephalomyocarditis. To investigate whether a polyC truncated, miRNA-detargeted oncolytic Mengovirus might be boosted, we partially or fully rebuilt the polyC tract into the 5' noncoding region (NCR) of polyC-deleted (MC&lt;sub>0&lt;/sub>) oncolytic constructs (NC) carrying miRNA target (miRT) insertions to eliminate cardiac/muscular (miR-133b and miR-208a) and neuronal (miR-124) tropisms. PolyC-reconstituted viruses (MC&lt;sub>24&lt;/sub>-NC and MC&lt;sub>37&lt;/sub>-NC) replicated &lt;i>in vitro&lt;/i> and showed the expected tropism restrictions, but reduced</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-04T12:37:29.288Z</modification><creation>2025-04-04T12:37:29.288Z</creation></dates><accession>S-EPMC9800256</accession><cross_references><pubmed>36619293</pubmed><doi>10.1016/j.omto.2022.11.006</doi></cross_references></HashMap>